Background Clinical trials in the research setting have demonstrated that primary human
papillomavirus (HPV)-based screening results in greater protection against cervical cancer …

Background Underserved ethnic minority women experience significant disparities in
cervical cancer incidence and mortality, mainly due to lack of cervical cancer screening …

Objectives Testing for human papillomavirus (HPV) infection has recently been introduced
into cervical screening programmes. We investigated (1) barriers to accessing and …

Objective Uptake for cervical cancer screening remains well below the 80% target as
recommended by Brunei's National Cervical Cancer Prevention and Control plan. We …

RACOMIP is a population‐based, randomized trial of the effectiveness and cost‐
effectiveness of different interventions aimed at increasing participation in a well‐run …

Background The human papillomavirus (HPV) test, administered alone without the
Papanicolaou (Pap) test, was recently recognized as a cervical cancer screening option in …

Cervical cancer screening guidelines in the United States were revised in 2018 to include
the option of primary human papillomavirus (HPV) testing. The transition to this screening …

Background Human papillomavirus (HPV) testing on self-samples represents a great
opportunity to increase cervical cancer screening uptake among under-screened women …

Cytology-based cervical cancer screening programs have been difficult to implement and
scale up in developing countries. Thus, the World Health Organization recommends a 'see …

Abstract The Human Papillomavirus FOr CervicAL cancer (HPV FOCAL) trial is a large
randomized controlled trial comparing the efficacy of primary HPV testing to cytology among …